Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of NVP-1805 vs Coadministration of NVP-1805-R1 and NVP-1805-R2
NCT04905342Phase 1Completed
- Sponsor
- NVP Healthcare Co., Ltd.
- Start
- Aug 2021
- Primary completion
- Dec 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of telmisartan, rosuvastatin and ezetimibe in hypertension (HTN) and dyslipidemia (2 arms), sponsored by NVP Healthcare Co., Ltd. Primary endpoints: Area Under the Curve from time zero to last quantifiable concentration and Maximum Plasma Concentration. Started Aug 2021; status: completed.
02
Drugs
telmisartanrosuvastatinezetimibe
03
Conditions
hypertension (HTN)dyslipidemia
Beyond the preview
Go deeper on NCT04905342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04905342.